Article Sidebar
Published:
Mar 17, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Retracted “Effect of Shensong Yangxin on heart failure in preserved ejection fraction rat model”
Abstract
This article previously published in Volume 17 Issue 12 of this journal in December 2018 has been retracted in line with the guidelines from the Committee on Publication Ethics (COPE, http://publicationethics.org/resources/guidelines).
Retraction: Zhang W, Sun Q, Chen H, Zhang Q. Effect of Shensong Yangxin on heart failure in preserved ejection fraction rat model. Trop J Pharm Res 2018; 17(12):2427-2432 doi: http://dx.doi.org/10.4314/tjpr.v17i12.17
To the editor:
Many readers have written to me with questions about my article. We have found out that there was an
omission in the experimental design hence some of the results could not be repeated. Therefore, we
decided that the paper should be retracted to avoid misleading the readers. Sincerely, Qian Sun.
Keywords: Heart failure, Ejection fraction, Shensong Yangxin
